Your mission The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research center dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases.
It was created in 2010, and since then has experienced an exponential growth.
The IJC is also part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024.
Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC) Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII).
The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services.
The IJC has six locations integrated into reference hospitals: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Trueta, Hospital del Mar and Hospital San Joan de Déu.
This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.
Research Description We are seeking a student with a master's in Bioinformatics to join the Transcriptional Dynamics in Leukemia group, led by Dr. Sergi Cuartero.
The team investigates how transcriptional regulators and chromatin modifiers contribute to normal blood differentiation and how their mutations lead to leukemia.
Our team includes both experimental and computational researchers, and the candidate will be guided by a senior bioinformatician in the group.
The main tasks will involve analysing sequencing data generated in the lab with the goal of uncovering novel mechanisms of transcriptional regulation in leukemia.
This contract is part of the grant PID2023-151180OB-I00 funded by MCIU/ AEI / 10.13039/501100011033 / FSE+" MAIN RESPONSIBILITIES Conducting a project aimed at understanding the mechanisms underlying gene expression deregulation in normal blood cells and leukemia.
Experimental design and deep exploration of complex datasets.
Analysis of next-generation sequencing datasets (RNA-seq, ATAC-seq, Hi-C).
Integration of epigenomic data with large-scale, public transcriptomic datasets.
Management of the databases related to the project.
Your profile WHAT WE NEED BSc degree in Biology or related degree MSc in Bioinformatics Proficient in writing and speaking in English Eager to learn and aptitude for teamwork Organized, proactive, self-motivated, and enthusiastic EVALUATION CRITERIA The evaluation criteria for the selection process are as follows: Criterion 1.
Academic and/or scientific-technical background of the candidate (up to 50 points) Criterion 2.
Suitability of the candidate to the research activities to be carried out (up to 50 points).
The candidate's suitability for the program, project, or research activities to be developed will be evaluated based on their prior education and experience.
The added value that carrying out the project will represent for the candidate's research career, as well as the value contributed to the center and the receiving team, will be taken into account.
Why us?
WHAT WE OFFER A FPI PhD position for 4 years funded by MCIN/AEI/10.13039/501100011033 and FSE+.
The stimulating environment of the Barcelona metropolitan area.
An exciting and innovative research project.
Incorporation in a well-established, dynamic and highly motivated team.
Working in the outstanding multidisciplinary research environment of the Josep Carreras Leukaemia Research Institute.
How to apply?
Please submit your application by December 15th, 2024.
About us What makes us different?
The mission of the Josep Carreras Institute is to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of cancer, with a special emphasis on leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases.
The IJC's vision is to be a world-class reference and excellent research multicampus that contributes to the improvement of results, and the cure of patients affected by leukemia and other malignant hemopathies, through innovation, sustainability, social responsibility, talent, and professional experience.
HR Excellence In 2019, IJC was honored with the "Human Resources Excellence in Research Award" by the European Commission, recognizing the alignment of our human resources policies with the European Charter for Researchers and Code of Conduct for the Recruitment of Researchers.
The Human Resources Strategy for Researchers (HRS4R) guides research centers of excellence in implementing and upholding these standards within their policies, emphasizing training, professional development, and mobility opportunities.
The IJC's commitment to these values and principles strengthens our internal policies and ensures that our members have the optimal conditions and environment for their professional development.
The IJC is an equal opportunity employer.
We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, or other legally protected characteristics.